Search Results for “Various” - Page 4

Flipping the switch on RP: SparingVision doses patients in their first in-human clinical trial for SPVN20

The latest research news from Retina UK.

Slowing sight loss in stargardts: Ocugen’s gene therapy trial offers promising early results

Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.

SparingVision completes dosing in PRODYGY trial of SPVNO6 for retinitis pigmentosa.

SparingVision have announced this week that they have dosed all participants in their phase 1/2 PRODYGY clinical trial for SPVN06, a gene agnostic therapy aimed at slowing disease progression in Retinitis Pigmentosa (RP).

A placeholder image which is a square with a white shape on it

Meet our Trustee: Vanessa Forster

Vanessa is the General Counsel at the Alan Turing Institute, the UK’s national data science and artificial intelligence research institute.

A man and a woman wearing smart clothes playing table tennis

How we can work together

We can provide all the support your organisation needs to work with us; from ideas to practical support and materials. The Retina UK team will help your contribution be as fun and rewarding as possible.

Looking after your vision

It is important to avoid harming your vision, particularly if you have an inherited sight loss condition.

Tough Mudder 2026

With various events to choose from in 2026, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!

Tough Mudder 2026 (London West)

With various events to choose from in 2026, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out in 2026.